Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer

Nicola Baldini, Angelo De Milito, Olivier Feron, Robert J. Gillies, Carine Michiels, Angela M. Otto, Silvia Pastoreková, Stine F. Pedersen, Paolo E. Porporato, Pierre Sonveaux, Claudiu T. Supuran, Sofia Avnet

Résultats de recherche: Contribution à un journal/une revueArticle

Résumé

Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

langueAnglais
Numéro d'article411
Nombre de pages5
journalFrontiers in Pharmacology
Volume8
NuméroJUL
Les DOIs
étatPublié - 2017

Empreinte digitale

Metabolic Networks and Pathways
Neoplasms
Precision Medicine
Belgium
Energy Metabolism
Recurrence
Food
Therapeutics

mots-clés

    Citer ceci

    Baldini, Nicola ; De Milito, Angelo ; Feron, Olivier ; Gillies, Robert J. ; Michiels, Carine ; Otto, Angela M. ; Pastoreková, Silvia ; Pedersen, Stine F. ; Porporato, Paolo E. ; Sonveaux, Pierre ; Supuran, Claudiu T. ; Avnet, Sofia. / Annual meeting of the International Society of Cancer Metabolism (ISCaM) : Metabolic networks in cancer. Dans: Frontiers in Pharmacology. 2017 ; Vol 8, Numéro JUL.
    @article{b5915798c4624e74bcbdc388202a0822,
    title = "Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer",
    abstract = "Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.",
    keywords = "Cancer imaging, Cancer therapy, Proton dynamics, Tumor metabolism, Tumor microenvironment",
    author = "Nicola Baldini and {De Milito}, Angelo and Olivier Feron and Gillies, {Robert J.} and Carine Michiels and Otto, {Angela M.} and Silvia Pastorekov{\'a} and Pedersen, {Stine F.} and Porporato, {Paolo E.} and Pierre Sonveaux and Supuran, {Claudiu T.} and Sofia Avnet",
    year = "2017",
    doi = "10.3389/fphar.2017.00411",
    language = "English",
    volume = "8",
    journal = "Frontiers in Pharmacology",
    issn = "1663-9812",
    publisher = "Frontiers Media S. A.",
    number = "JUL",

    }

    Baldini, N, De Milito, A, Feron, O, Gillies, RJ, Michiels, C, Otto, AM, Pastoreková, S, Pedersen, SF, Porporato, PE, Sonveaux, P, Supuran, CT & Avnet, S 2017, 'Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer' Frontiers in Pharmacology, VOL. 8, Numéro JUL, 411. https://doi.org/10.3389/fphar.2017.00411

    Annual meeting of the International Society of Cancer Metabolism (ISCaM) : Metabolic networks in cancer. / Baldini, Nicola; De Milito, Angelo; Feron, Olivier; Gillies, Robert J.; Michiels, Carine; Otto, Angela M.; Pastoreková, Silvia; Pedersen, Stine F.; Porporato, Paolo E.; Sonveaux, Pierre; Supuran, Claudiu T.; Avnet, Sofia.

    Dans: Frontiers in Pharmacology, Vol 8, Numéro JUL, 411, 2017.

    Résultats de recherche: Contribution à un journal/une revueArticle

    TY - JOUR

    T1 - Annual meeting of the International Society of Cancer Metabolism (ISCaM)

    T2 - Frontiers in Pharmacology

    AU - Baldini, Nicola

    AU - De Milito, Angelo

    AU - Feron, Olivier

    AU - Gillies, Robert J.

    AU - Michiels, Carine

    AU - Otto, Angela M.

    AU - Pastoreková, Silvia

    AU - Pedersen, Stine F.

    AU - Porporato, Paolo E.

    AU - Sonveaux, Pierre

    AU - Supuran, Claudiu T.

    AU - Avnet, Sofia

    PY - 2017

    Y1 - 2017

    N2 - Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

    AB - Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

    KW - Cancer imaging

    KW - Cancer therapy

    KW - Proton dynamics

    KW - Tumor metabolism

    KW - Tumor microenvironment

    UR - http://www.scopus.com/inward/record.url?scp=85025467140&partnerID=8YFLogxK

    U2 - 10.3389/fphar.2017.00411

    DO - 10.3389/fphar.2017.00411

    M3 - Article

    VL - 8

    JO - Frontiers in Pharmacology

    JF - Frontiers in Pharmacology

    SN - 1663-9812

    IS - JUL

    M1 - 411

    ER -